Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunometabolic Signature in Long COVID-19
NCT05758480Completed
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- May 2023
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoints: Presence of immunometabolic signatures specific of Long COVID in the plasma and mononuclear cells at 18 months and Concentration of metabolites and immune mediators in the plasma and mononuclear cells at 18 months. Started May 2023; status: completed.
Beyond the preview
Go deeper on NCT05758480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05758480.